nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A case of pulmonary veno-occlusive disease: diagnostic dilemmas and therapeutic challenges
|
Sourla, Evdokia |
|
2013 |
|
2 |
p. 119-123 |
artikel |
2 |
Adjunctive drug therapies for treatment of respiratory diseases in the newborn: based on evidence or habit?
|
Sinha, Sunil |
|
2014 |
|
2 |
p. 53-62 |
artikel |
3 |
A new strategy with proton pump inhibitors for the prevention of acute exacerbations in COPD
|
Sasaki, Takahiko |
|
2011 |
|
2 |
p. 91-103 |
artikel |
4 |
Arformoterol and salmeterol in the treatment of chronic obstructive pulmonary disease: A one year evaluation of safety and tolerance
|
Donohue, J.F. |
|
2008 |
|
2 |
p. 37-48 |
artikel |
5 |
Arterio-venous access in end-stage renal disease patients and pulmonary hypertension
|
Yigla, Mordechai |
|
2008 |
|
2 |
p. 49-53 |
artikel |
6 |
Best practices in the treatment of early cystic fibrosis lung disease
|
Proesmans, Marijke |
|
2017 |
|
2 |
p. 97-104 |
artikel |
7 |
Bronchial thermoplasty: a novel technique in the treatment of severe asthma
|
Castro, Mario |
|
2010 |
|
2 |
p. 101-116 |
artikel |
8 |
Bronchial thermoplasty: a novel technique in the treatment of severe asthma
|
Castro, Mario |
|
2010 |
|
2 |
p. 101-116 |
artikel |
9 |
Bronchoscopic staging of lung cancer
|
Hanna, Waël C. |
|
2013 |
|
2 |
p. 111-118 |
artikel |
10 |
Changing epidemiology and clinical issues arising in an ageing cystic fibrosis population
|
Parkins, Michael D. |
|
2011 |
|
2 |
p. 105-119 |
artikel |
11 |
Clinical and pharmacoeconomic aspects of omalizumab: a 4-year follow-up
|
Menzella, Francesco |
|
2012 |
|
2 |
p. 87-95 |
artikel |
12 |
Clinical and pharmacoeconomic profile of COPD patients with FEV1 50—60% predicted: pilot study on the impact of the extended indication of ICS/LABA
|
Dal Negro, Roberto Walter |
|
2009 |
|
2 |
p. 51-58 |
artikel |
13 |
Clinical assessment of the obstructive sleep apnoea/hypopnoea syndrome
|
Riha, Renata L. |
|
2010 |
|
2 |
p. 83-91 |
artikel |
14 |
Clinical assessment of the obstructive sleep apnoea/hypopnoea syndrome
|
Riha, Renata L. |
|
2010 |
|
2 |
p. 83-91 |
artikel |
15 |
Clinicopharmacological profile of the fixed-dose combination of aclidinium bromide and formoterol fumarate in the management of chronic obstructive pulmonary disease
|
Babu, K. Suresh |
|
2015 |
|
2 |
p. 56-68 |
artikel |
16 |
Combination therapy with indacaterol and glycopyrronium bromide in the management of COPD: an update on the evidence for efficacy and safety
|
Ridolo, Erminia |
|
2015 |
|
2 |
p. 49-55 |
artikel |
17 |
Comparative efficacy of fixed-dose combinations of long-acting muscarinic antagonists and long-acting β2-agonists: a systematic review and network meta-analysis
|
Schlueter, Max |
|
2016 |
|
2 |
p. 89-104 |
artikel |
18 |
Correlation of symptoms with total IgE and specific IgE levels in patients presenting with allergic rhinitis
|
Karli, Rifat |
|
2013 |
|
2 |
p. 75-79 |
artikel |
19 |
Corrigendum
|
|
|
2011 |
|
2 |
p. 151-151 |
artikel |
20 |
Corrigendum
|
|
|
2011 |
|
2 |
p. 151 |
artikel |
21 |
Current best practice in rehabilitation in interstitial lung disease
|
Nakazawa, Atsuhito |
|
2017 |
|
2 |
p. 115-128 |
artikel |
22 |
Current best practice in the evaluation and management of malignant pleural effusions
|
Walker, Steven |
|
2017 |
|
2 |
p. 105-114 |
artikel |
23 |
Diagnostics and epidemiology in ventilator-associated pneumonia
|
Shorr, Andrew F. |
|
2011 |
|
2 |
p. 121-130 |
artikel |
24 |
Editorial The significance of tissue-imaging proteomics in respiratory therapies
|
Xiangdong Wang, |
|
2007 |
|
2 |
p. 81-83 |
artikel |
25 |
Effects of tiotropium and formoterol on quiet breathing pattern assessed by optoelectronic plethysmography in COPD patients: a pilot study
|
Dal Negro, Roberto Walter |
|
2012 |
|
2 |
p. 97-105 |
artikel |
26 |
Efficacy and safety profile of autologous blood versus tetracycline pleurodesis for malignant pleural effusion
|
Keeratichananont, Warangkana |
|
2015 |
|
2 |
p. 42-48 |
artikel |
27 |
Enhancing adherence to inhaled therapies in cystic fibrosis
|
Lomas, Paula |
|
2014 |
|
2 |
p. 39-47 |
artikel |
28 |
Erratum
|
|
|
2010 |
|
2 |
p. 129-129 |
artikel |
29 |
Erratum
|
|
|
2010 |
|
2 |
p. 129 |
artikel |
30 |
Ethnic differences in alpha-1 antitrypsin deficiency in the United States of America
|
de Serres, Frederick J. |
|
2010 |
|
2 |
p. 63-70 |
artikel |
31 |
Ethnic differences in alpha-1 antitrypsin deficiency in the United States of America
|
de Serres, Frederick J. |
|
2010 |
|
2 |
p. 63-70 |
artikel |
32 |
Evaluation of a 24-hour emergency bronchoscopy service in a tertiary care hospital
|
Fuehner, Thomas |
|
2009 |
|
2 |
p. 65-71 |
artikel |
33 |
Exhaled nitric oxide in the diagnosis and management of childhood asthma
|
Kercsmar, Carolyn |
|
2010 |
|
2 |
p. 71-82 |
artikel |
34 |
Exhaled nitric oxide in the diagnosis and management of childhood asthma
|
Kercsmar, Carolyn |
|
2010 |
|
2 |
p. 71-82 |
artikel |
35 |
Exhaled nitric oxide, systemic inflammation, and the spirometric response to inhaled fluticasone propionate in severe chronic obstructive pulmonary disease: A prospective study
|
Kunisaki, Ken M. |
|
2008 |
|
2 |
p. 55-64 |
artikel |
36 |
Factors determining the quality of life of patients with COPD in primary care
|
Miravitlles, Marc |
|
2007 |
|
2 |
p. 85-92 |
artikel |
37 |
Is there a role for e-cigarettes in smoking cessation?
|
Leduc, Charlotte |
|
2016 |
|
2 |
p. 130-135 |
artikel |
38 |
Long-term respiratory outcome of babies born prematurely
|
Ali, Kamal |
|
2012 |
|
2 |
p. 115-120 |
artikel |
39 |
Management of advanced non-small cell lung cancers with known mutations or rearrangements: latest evidence and treatment approaches
|
Shea, Meghan |
|
2016 |
|
2 |
p. 113-129 |
artikel |
40 |
Management of asthma during pregnancy
|
Maselli, Diego J. |
|
2013 |
|
2 |
p. 87-100 |
artikel |
41 |
Management of multidrug-resistant tuberculosis: an update
|
Monedero, Ignacio |
|
2010 |
|
2 |
p. 117-127 |
artikel |
42 |
Management of multidrug-resistant tuberculosis: an update
|
Monedero, Ignacio |
|
2010 |
|
2 |
p. 117-127 |
artikel |
43 |
Nebulized arformoterol: what is its place in the management of COPD?
|
Miles, Matthew C. |
|
2013 |
|
2 |
p. 81-86 |
artikel |
44 |
New treatment options for bronchiectasis
|
Metersky, Mark L. |
|
2010 |
|
2 |
p. 93-99 |
artikel |
45 |
New treatment options for bronchiectasis
|
Metersky, Mark L. |
|
2010 |
|
2 |
p. 93-99 |
artikel |
46 |
Pirfenidone treatment of idiopathic pulmonary fibrosis
|
Azuma, Arata |
|
2012 |
|
2 |
p. 107-114 |
artikel |
47 |
Pulmonary artery diastolic pressure gradient as an indicator of severity of illness in patients with pulmonary hypertension related to left-sided heart disease
|
Howard, Christopher |
|
2015 |
|
2 |
p. 35-41 |
artikel |
48 |
Rapid and partial remission of primary lesion but complicated by secondary fibrosis after treatment with nivolumab in a lung squamous carcinoma
|
Ding, Ling |
|
2017 |
|
2 |
p. 129-132 |
artikel |
49 |
Rare alpha-1-antitrypsin variants: are they really so rare?
|
Rodriguez-Frias, Francisco |
|
2012 |
|
2 |
p. 79-85 |
artikel |
50 |
Reduction of severe exacerbations and hospitalization-derived costs in alpha-1-antitrypsin-deficient patients treated with alpha-1-antitrypsin augmentation therapy
|
Barros-Tizón, Juan Carlos |
|
2012 |
|
2 |
p. 67-78 |
artikel |
51 |
Reporting of central airway obstruction on radiology reports and impact on bronchoscopic airway interventions and patient outcomes
|
Harris, Kassem |
|
2016 |
|
2 |
p. 105-112 |
artikel |
52 |
Review: A new strategy with proton pump inhibitors for the prevention of acute exacerbations in COPD
|
Sasaki, Takahiko |
|
2011 |
|
2 |
p. 91-103 |
artikel |
53 |
Review: Changing epidemiology and clinical issues arising in an ageing cystic fibrosis population
|
Parkins, Michael D. |
|
2011 |
|
2 |
p. 105-119 |
artikel |
54 |
Review: Diagnostics and epidemiology in ventilator-associated pneumonia
|
Shorr, Andrew F. |
|
2011 |
|
2 |
p. 121-130 |
artikel |
55 |
Review: New perspectives in the treatment of idiopathic pulmonary fibrosis
|
Rogliani, Paola |
|
2008 |
|
2 |
p. 75-93 |
artikel |
56 |
Review: Strategies in the prevention of ventilator-associated pneumonia
|
Maselli, Diego J. |
|
2011 |
|
2 |
p. 131-141 |
artikel |
57 |
Review: Surfactant protein D: A lung specific biomarker in COPD?
|
Sin, Don D. |
|
2008 |
|
2 |
p. 65-74 |
artikel |
58 |
Review: The potential role of natural agents in treatment of airway inflammation
|
Sharafkhaneh, Amir |
|
2007 |
|
2 |
p. 105-120 |
artikel |
59 |
Review: The relationship between gastroesophageal reflux and asthma: an update
|
McCallister, Jennifer W. |
|
2011 |
|
2 |
p. 143-150 |
artikel |
60 |
Review: Treating patients with respiratory disease who smoke
|
Braganza, Georgina |
|
2008 |
|
2 |
p. 95-107 |
artikel |
61 |
Smoking cessation treatment in a real-life setting: the Greek experience
|
Rovina, Nikoletta |
|
2007 |
|
2 |
p. 93-104 |
artikel |
62 |
Strategies in the prevention of ventilator-associated pneumonia
|
Maselli, Diego J. |
|
2011 |
|
2 |
p. 131-141 |
artikel |
63 |
The challenge of diagnosing a mixed asthma–COPD phenotype (ACOS) in clinical practice
|
García-García, María del Carmen |
|
2016 |
|
2 |
p. 175-178 |
artikel |
64 |
The effects of inhaled and oral corticosteroids on serum inflammatory biomarkers in COPD: an exploratory study
|
Man, S.F. Paul |
|
2009 |
|
2 |
p. 73-80 |
artikel |
65 |
The evolving landscape of combination therapy for pulmonary arterial hypertension
|
Griffin, Matthew |
|
2017 |
|
2 |
p. 91-95 |
artikel |
66 |
The impact of LABA+ICS fixed combinations on morbidity and economic burden of COPD in Italy: a six-year observational study
|
Dal Negro, Roberto |
|
2011 |
|
2 |
p. 83-90 |
artikel |
67 |
The impact of LABA+ICS fixed combinations on morbidity and economic burden of COPD in Italy: a six-year observational study
|
Dal Negro, Roberto |
|
2011 |
|
2 |
p. 83-90 |
artikel |
68 |
The potential role and limitations of echocardiography in acute respiratory distress syndrome
|
Lazzeri, Chiara |
|
2016 |
|
2 |
p. 136-148 |
artikel |
69 |
The relationship between gastroesophageal reflux and asthma: an update
|
McCallister, Jennifer W. |
|
2011 |
|
2 |
p. 143-150 |
artikel |
70 |
The role of NIV in chronic hypercapnic COPD following an acute exacerbation: the importance of patient selection?
|
Duiverman, Marieke L. |
|
2016 |
|
2 |
p. 149-157 |
artikel |
71 |
The role of viral infections in exacerbations of chronic obstructive pulmonary disease and asthma
|
Hewitt, Richard |
|
2016 |
|
2 |
p. 158-174 |
artikel |
72 |
The use of high-flow nasal oxygen therapy in the management of hypercarbic respiratory failure
|
Millar, Jonathan |
|
2014 |
|
2 |
p. 63-64 |
artikel |
73 |
Tracheobronchial amyloidosis managed with multimodality therapies
|
Sommer, Philip |
|
2014 |
|
2 |
p. 48-52 |
artikel |
74 |
Transplanting the adolescent cystic fibrosis patient: can we do it?
|
Oshrine, Kathleen |
|
2013 |
|
2 |
p. 101-109 |
artikel |
75 |
Use of dry powder inhalers in acute exacerbations of asthma and COPD
|
Selroos, Olof |
|
2009 |
|
2 |
p. 81-91 |
artikel |
76 |
Value of adding a polyvalent mechanical bacterial lysate to therapy of COPD patients under regular treatment with salmeterol/fluticasone
|
Cazzola, Mario |
|
2009 |
|
2 |
p. 59-63 |
artikel |